80 related articles for article (PubMed ID: 12212162)
1. [Relationship between the expression of bcl-2 apoptosis and acute myelogenous leukemia prognosis].
Liu J; Cao P; Qi ZH
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):265-6. PubMed ID: 12212162
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
Daneshbod Y; Amirghofran Z; Tabei SZ
Neoplasma; 2005; 52(2):109-14. PubMed ID: 15800708
[TBL] [Abstract][Full Text] [Related]
3. [WT1 gene expression in leukemia patients and its correlation with prognosis and multidrug resistance].
Guo X; Xu S; Dong Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):69-72. PubMed ID: 11601201
[TBL] [Abstract][Full Text] [Related]
4. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between clinical prognosis and classification of the isoforms of fuse gene in acute promyelocytic leukemia].
Liu J; Qi ZH; Cao P
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):564-6. PubMed ID: 12516405
[TBL] [Abstract][Full Text] [Related]
6. [Bcl-2 mRNA expression in acute promyelocytic leukemia by RT-PCR].
Liu J; Qi Z; Jian Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):503-4. PubMed ID: 10682575
[TBL] [Abstract][Full Text] [Related]
7. [Expression of bcl-2 gene in the evolution of chronic myelogenous leukemia to blast crisis and its implication].
Sui X; Su L; Chu J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):27-9. PubMed ID: 11498840
[TBL] [Abstract][Full Text] [Related]
8. [Detection and evaluation of bcl-x and bcl-2 gene expression in blasts from patients with acute leukemia].
Shen X; Wang C; Qiao Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):350-3. PubMed ID: 11721430
[TBL] [Abstract][Full Text] [Related]
9. [Expression of bcl-2 in acute leukemia patients and its significance].
Jian ZF; Zhou YH; Chen FP
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):397-8. PubMed ID: 12206015
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
[TBL] [Abstract][Full Text] [Related]
11. [Expression of bcl-2, c-myc genes and their relationship in patients with acute leukemia].
Chen SP; Tang GC
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):83-5. PubMed ID: 12536628
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
13. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
You JQ; Wang P
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
[TBL] [Abstract][Full Text] [Related]
14. Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90.
Ryningen A; Ersvaer E; Øyan AM; Kalland KH; Vintermyr OK; Gjertsen BT; Bruserud Ø
Leuk Res; 2006 Dec; 30(12):1531-40. PubMed ID: 16600371
[TBL] [Abstract][Full Text] [Related]
15. [Relation between Bcl-2 protein expression and results of therapy in patients with acute myeloblastic leukemia].
Tóthová E; Stecová N; Kafková A; Fricová M; Guman T; Elbertová A
Vnitr Lek; 2004 Feb; 50(2):139-42. PubMed ID: 15077589
[TBL] [Abstract][Full Text] [Related]
16. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.
Tóthová E; Fricova M; Stecová N; Kafková A; Elbertová A
Neoplasma; 2002; 49(3):141-4. PubMed ID: 12097997
[TBL] [Abstract][Full Text] [Related]
17. The rate of apoptosis and expression of Bcl-2 and Bax in leukocytes of acute myeloblastic leukemia patients.
Dabrowska M; Pietruczuk M; Kostecka I; Suchowierska M; Kloczko J; Nasilowska B; Bany-Laszewicz U; Marianska B
Neoplasma; 2003; 50(5):339-44. PubMed ID: 14628086
[TBL] [Abstract][Full Text] [Related]
18. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
19. Significance in acute myeloid leukemia (AML) of bcl-2 protein expression.
Díez-Martin JL; Gayoso J; Romero R
Haematologica; 1997; 82(6):729-30. PubMed ID: 9499680
[No Abstract] [Full Text] [Related]
20. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
